Corning, New York — Corning Incorporated (NYSE: GLW) today announced that a leading pharmaceutical company has been approved by the US Food and Drug Administration (FDA) to use Corning Valor® Glass as the primary packaging for marketed drugs.
Valor Glass is specifically designed for pharmaceutical applications. This approval makes Valor Glass the first and only new glass component approved by the FDA since the advent of borosilicate glass more than 100 years ago.
This innovative glass packaging solution provides excellent chemical stability and resistance to breakage, breakage, and contamination of glass microparticles. These features help drug manufacturers increase drug output, ensure drug quality and improve production efficiency.
Wei Wende, Chairman of the Board, CEO and President:
"We are thrilled to reach this important milestone. We sincerely cooperate with customers to work together to explore life-changing innovations and jointly realize the modernization process of this glass packaging material. We also want to extend our sincere heart to the FDA's emerging technology team Thank you. Valor Glass and many other innovative technologies are inseparable from their unremitting efforts. "
Ronald Verkleeren, Vice President and General Manager of Pharmaceutical Technology:
"We are convinced that Valor Glass is the future of pharmaceutical glass packaging for pharmaceutical companies. This FDA approval is an important first step in our journey to create new standards for pharmaceutical glass packaging. For patients, for the pharmaceutical industry and Corning, this is a Great news. "